Statements (56)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:DJ
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Omicron_XBB.1.16
|
gptkbp:allows |
considered in some regions
|
gptkbp:associated_with |
Omicron variant
|
gptkbp:characteristics |
high transmissibility
|
gptkbp:clinical_trial |
in progress
|
gptkbp:collaborations |
international health organizations
|
gptkbp:community |
documented
actively researching |
gptkbp:community_impact |
gptkb:significant
|
gptkbp:data_usage |
higher than previous variants
|
gptkbp:genetic_diversity |
ongoing
ongoing research evolving rapidly important for tracking |
gptkbp:has_transformation |
Spike protein mutations
|
gptkbp:has_variants |
may influence future variants
|
gptkbp:has_voice_line |
XBB.1, XBB.2, XBB.3
|
gptkbp:healthcare |
gptkb:battle
necessary enhanced monitoring adapted to new variants affected by variants. being analyzed |
https://www.w3.org/2000/01/rdf-schema#label |
XBB lineage
|
gptkbp:impact |
on vaccine development
|
gptkbp:is_a |
gptkb:drug
|
gptkbp:is_monitored_by |
gptkb:World_Health_Organization
critical for response CDC, WHO |
gptkbp:is_recognized_by |
gptkb:India
|
gptkbp:is_vulnerable_to |
being collected
higher than earlier strains reduced against severe disease |
gptkbp:origin |
continuing
still under investigation |
gptkbp:premiered_on |
BA.2 lineage
|
gptkbp:provides_information_on |
updated regularly
critical for understanding adapted accordingly |
gptkbp:public_awareness |
increasing
|
gptkbp:recognizes |
multiple countries
|
gptkbp:related_model |
Variant of Concern
|
gptkbp:reports_to |
increasing globally
|
gptkbp:research |
ongoing
|
gptkbp:research_focus |
ongoing studies
|
gptkbp:responds_to |
varies by population
|
gptkbp:side_effect |
gptkb:significant
being assessed |
gptkbp:symptoms |
similar to COVID-19
|
gptkbp:track |
key strategy
essential for public health |
gptkbp:treatment |
similar to other variants
|
gptkbp:variant |
under study
important for control measures |